SMAD2 and Huntington disease: ELISA and immunoblot analysis of key TGF-β signaling pathway proteins revealed elevated levels of the TGF-β cytokine (Fig. 4A) and enhanced canonical SMAD signaling, evidenced by increased phosphorylation of SMAD2/3, in HCT116-MD and HD cells (Fig. 4B).